Protara Therapeutics Inc

NASDAQ:TARA  
3.45
+0.14 (+4.23%)
Earnings Announcements

Protara Therapeutics Q1 Loss Per Share $0.96

Published: 05/05/2022 13:04 GMT
Protara Therapeutics Inc (TARA) - Q1 Loss per Share $0.96.
Protara - Strong Cash, Cash Equivalents and Investments Position of $119 Million As of March 31, 2022 Expected to Fund Operations Into Mid-2024.
Qtrly Loss per Share $0.96.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.94

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$1.06

More details on our Analysts Page.